Multi-omics Market - Top Companies and Manufacturers

  • Report ID: 6091
  • Published Date: May 30, 2024
  • Report Format: PDF, PPT

Companies Dominating the Multi-Omics Landscape

    Important companies apply for product approvals in order to expand as a means of improving production and development efforts as well as to broaden the product's appeal and availability in a variety of geographic locations. Furthermore, a number of businesses are purchasing smaller competitors in an effort to improve their market share.

    • Becton, Dickinson and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Danaher Corporation
    • PerkinElmer, Inc.
    • Bruker
    • Centogene N.V.
    • Element Biosciences
    • QIAGEN
    • Agilent Technologies, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Element Biosciences, Inc., innovative scientific technology supplier announced a collaboration with Precision Health Data Cloud leader DNAnexus. Customers can now easily transfer data from Element's AVITITM System to their DNAnexus accounts thanks to this partnership. Customers can leverage a powerful combination of capabilities by combining the outstanding performance of AVITI sequencing with the safe and extensive multi-omic analysis platform offered by DNAnexus.
  • Centogene N.V. has announced the addition of cutting-edge transcriptome analysis to its MOx diagnostic portfolio. This single-step multi-omic system, called MOx 2.0, combines biochemical testing, DNA sequencing, and recently introduced RNA sequencing to provide healthcare practitioners with an unmatched depth of diagnostic capabilities.

Author Credits:  Radhika Pawar


  • Report ID: 6091
  • Published Date: May 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of multi-omics was over USD 2.5 billion.

The market size for multi-omics is projected to cross USD 15.5 billion by the end of 2036 expanding at a CAGR of 15.1% during the forecast period i.e., between 2024-2036.

The major players in the market are Thermo Fisher Scientific, Inc., Illumina, Inc., Danaher Corporation, PerkinElmer, Inc., Bruker, Centogene N.V., Element Biosciences, QIAGEN, Agilent Technologies, Inc., and others.

The academic & research institutes segment is anticipated to garner a share of 60% during 2024-2036.

The North America multi-omics sector is poised to hold 40% share by the end of 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample